spacer
home > ebr > spring 2002 > editor's letter
PUBLICATIONS
European Biopharmaceutical Review

Editor's Letter

"To merge or not to merge?" That does indeed seem to be a pertinent question, given the capital market conditions in Europe and elsewhere in the biotech business at present. And it's been like that for some time now if one compares the number of IPOs in Europe in 2001 (four compared with approximately 40 the year before). Although 2000 was clearly an exceptional year in the life science business, prospects for a listing remain poor today - on whichever side of the Atlantic you happen to be sitting. Given this reality, consolidation seems not only logical, but essential for the survival and growth of European life science companies. Is consolidation happening? There is some evidence to suggest that it is in the US, according to the article from Neal Ransome, European Leader of PricewaterhouseCoopers' Healthcare Corporate Finance Team. However, it seems that the trend is being driven by 'big biotech' companies (more akin to big pharma), rather than by small and medium biotech.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement